Cargando…

Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19()

The outcome of the SARS-CoV-2 (COVID-19) infection fundamentally affects the lung field, causing ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS). This process is an inflammatory picture, involving an NLRP3 INFLAMOSOME-triggered cytokine storm, the main player in alveolar destruction. IL-1 beta stands out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Jiménez, Alejandro, Rubio-Romero, Esteban, Fuente, José Luis Marenco de la
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. 2021
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041148/ https://www.ncbi.nlm.nih.gov/pubmed/32482538 http://dx.doi.org/10.1016/j.reumae.2020.04.012

Ejemplares similares

Propuesta de uso de anakinra en el distrés respiratorio agudo secundario a COVID-19
por: Muñoz-Jiménez, Alejandro, et al.
Publicado: (2021)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab()
por: Figuero-Pérez, Luis, et al.
Publicado: (2021)

High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
por: Iglesias-Julián, Enrique, et al.
Publicado: (2020)

Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19 †
por: García-García, José A, et al.
Publicado: (2021)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Consensus for the management of analgesia, sedation and delirium in adults with COVID-19-associated acute respiratory distress syndrome
por: Donato, Manuel, et al.
Publicado: (2021)

A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failure
por: Denault, André Y., et al.
Publicado: (2020)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Phospholipases A2 as biomarkers in acute respiratory distress syndrome
por: Kitsiouli, Eirini, et al.
Publicado: (2021)

Acute respiratory distress syndrome: focusing on secondary injury
por: Pan, Pan, et al.
Publicado: (2021)

Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
por: Moore, Hunter B., et al.
Publicado: (2020)

Continuous positive airway pressure in managing acute respiratory distress in children in district hospitals: evidence for scale-up
por: Baiden, Frank, et al.
Publicado: (2021)

Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)
por: Emeriaud, Guillaume, et al.
Publicado: (2023)

Anakinra for the treatment of adult secondary HLH: a retrospective experience
por: Naymagon, Leonard
Publicado: (2022)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Peritoneal Membrane Oxygenation Therapy for Rats With Acute Respiratory Distress Syndrome
por: Legband, Nathan, et al.
Publicado: (2016)

Evolution of Acute Respiratory Distress Syndrome in Emergency and Critical Care: Therapeutic Management before and during the Pandemic Situation
por: Granados-Bolivar, Monserrat E., et al.
Publicado: (2022)

Acute respiratory distress syndrome: does histology matter?
por: Lorente, José A., et al.
Publicado: (2015)

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
por: Dimopoulos, George, et al.
Publicado: (2020)

Hypoxemic Respiratory Failure from Acute Respiratory Distress Syndrome Secondary to Leptospirosis
por: Fernando, Shannon M., et al.
Publicado: (2017)

Non-invasive respiratory support paths in hospitalized patients with COVID-19: proposal of an algorithm
por: Winck, J.C., et al.
Publicado: (2021)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

The Treatment of Acute Respiratory Distress Syndrome in Rats With a Peritoneal Dosing System
por: Legband, Nathan, et al.
Publicado: (2015)

Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study
por: Weiss, Tyler T., et al.
Publicado: (2021)

Neutrophils and secondary infections in COVID-19 induced acute respiratory distress syndrome
por: Holliday, Z.M., et al.
Publicado: (2021)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Acute Respiratory Distress
por: Maloy, James, et al.
Publicado: (2018)

Acute respiratory distress secondary to posterior mediastinal goiter: a case report
por: Jaroszewski, Dawn E, et al.
Publicado: (2009)

Acute Respiratory Distress Syndrome Secondary to Enterovirus-Human-Rhinovirus Infection in an Adult
por: Hamid, Khizar, et al.
Publicado: (2022)

Anakinra reduces lung inflammation in experimental acute lung injury
por: Engeroff, Paul, et al.
Publicado: (2021)

Anakinra: Jaundice: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f8l71mludgfsqtegg0lk48f7vu